Legal & General Group PLC Bluebird Bio, Inc. Transaction History

Legal & General Group PLC

  • $470 Billion
  • Q3 2024

A detailed history of Legal & General Group PLC transactions in Bluebird Bio, Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 18,801 shares of BLUE stock, worth $6,016. This represents 0.0% of its overall portfolio holdings.

Number of Shares
18,801
Previous 18,801 -0.0%
Holding current value
$6,016
Previous $9,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$0.47 - $1.35 $124,814 - $358,508
-265,562 Reduced 93.39%
18,801 $9,000
Q2 2024

Aug 14, 2024
SELL
$0.85 - $1.26 $46,167 - $68,436
-54,315 Reduced 16.04%
284,363 $278,000
Q1 2024

May 14, 2024
BUY
$0.91 - $1.75 $299,631 - $576,213
329,265 Added 3497.98%
338,678 $433,000
Q4 2023

Feb 15, 2024
SELL
$1.32 - $4.83 $124,403 - $455,203
-94,245 Reduced 90.92%
9,413 $12,000
Q3 2023

Nov 14, 2023
SELL
$3.02 - $4.05 $926,834 - $1.24 Million
-306,899 Reduced 74.75%
103,658 $315,000
Q2 2023

Aug 14, 2023
BUY
$2.79 - $5.03 $1.03 Million - $1.86 Million
369,774 Added 906.69%
410,557 $1.35 Million
Q1 2023

May 15, 2023
BUY
$3.14 - $8.22 $39,906 - $104,467
12,709 Added 45.27%
40,783 $129,000
Q4 2022

Feb 14, 2023
BUY
$5.77 - $8.49 $119,444 - $175,751
20,701 Added 280.77%
28,074 $194,000
Q3 2022

Nov 14, 2022
BUY
$3.75 - $7.39 $5,325 - $10,493
1,420 Added 23.85%
7,373 $47,000
Q2 2022

Aug 22, 2022
SELL
$2.94 - $5.23 $60,358 - $107,371
-20,530 Reduced 77.52%
5,953 $25,000
Q1 2022

May 16, 2022
SELL
$4.07 - $10.6 $118,038 - $307,421
-29,002 Reduced 52.27%
26,483 $129,000
Q3 2021

Nov 15, 2021
BUY
$11.24 - $21.0 $149,143 - $278,649
13,269 Added 31.43%
55,485 $1.06 Million
Q2 2021

Aug 12, 2021
BUY
$18.04 - $22.09 $1,749 - $2,142
97 Added 0.23%
42,216 $1.35 Million
Q1 2021

May 17, 2021
BUY
$16.59 - $33.89 $73,709 - $150,573
4,443 Added 11.79%
42,119 $1.27 Million
Q4 2020

Feb 12, 2021
SELL
$27.5 - $37.92 $382,305 - $527,163
-13,902 Reduced 26.95%
37,676 $1.63 Million
Q3 2020

Nov 13, 2020
SELL
$34.44 - $43.75 $3,857 - $4,900
-112 Reduced 0.22%
51,578 $2.78 Million
Q2 2020

Aug 14, 2020
BUY
$27.12 - $45.97 $318,985 - $540,699
11,762 Added 29.46%
51,690 $3.16 Million
Q1 2020

May 14, 2020
SELL
$26.16 - $63.5 $3,819 - $9,271
-146 Reduced 0.36%
39,928 $1.84 Million
Q4 2019

Feb 13, 2020
BUY
$46.96 - $61.67 $240,435 - $315,750
5,120 Added 14.65%
40,074 $3.52 Million
Q3 2019

Nov 13, 2019
BUY
$59.47 - $93.1 $313,347 - $490,543
5,269 Added 17.75%
34,954 $3.21 Million
Q2 2019

Aug 14, 2019
BUY
$75.84 - $105.21 $44,366 - $61,547
585 Added 2.01%
29,685 $3.78 Million
Q1 2019

May 15, 2019
BUY
$64.44 - $104.11 $163,419 - $264,022
2,536 Added 9.55%
29,100 $4.58 Million
Q4 2018

Feb 15, 2019
BUY
$59.1 - $93.26 $152,537 - $240,704
2,581 Added 10.76%
26,564 $2.64 Million
Q3 2018

Nov 20, 2018
BUY
$88.86 - $117.49 $106,720 - $141,105
1,201 Added 5.27%
23,983 $3.5 Million
Q2 2018

Aug 10, 2018
BUY
$99.64 - $127.59 $209,841 - $268,704
2,106 Added 10.19%
22,782 $3.58 Million
Q1 2018

May 17, 2018
SELL
$105.8 - $150.94 $161,450 - $230,334
-1,526 Reduced 6.87%
20,676 $3.53 Million
Q4 2017

Feb 13, 2018
BUY
$81.25 - $130.7 $1.8 Million - $2.9 Million
22,202
22,202 $3.96 Million

Others Institutions Holding BLUE

# of Institutions
152
Shares Held
63.7M
Call Options Held
264K
Put Options Held
428K
View Full List

About bluebird bio, Inc.

BLUE Quotes by TradingView
  • Ticker BLUE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,121,800
  • Market Cap $24.7M
  • Description
  • bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...
More about BLUE
Track This Portfolio

Track Legal & General Group PLC Portfolio

Follow Legal & General Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email